Internal Medicine · Greenwood, MS
NPI
1326008913
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1317 River Rd
Greenwood, MS, 38930
Phone (662) 459-2520
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
508 services
Medicare patients, 2024
257
Average age 70
Drug cost, 2024
$821K
3,418 prescriptions
Company payments, 2025
$127
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ravi Pande was code 99213 (office e&m - established), 330 times for 188 patients. In total Ravi Pande billed 508 services in 10 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 330 | 188 | $38.29 | $13K |
| 99204 Office E&M - New | Facility | 58 | 58 | $87.86 | $5,096 |
| 99223 Hospital E&M - Initial | Facility | 36 | 34 | $126.26 | $4,546 |
| 99215 Office E&M - Established | Facility | 29 | 29 | $98.25 | $2,849 |
| 99231 Hospital E&M - Subsequent | Facility | 20 | 12 | $36.30 | $726 |
| 99214 Office E&M - Established | Facility | 19 | 17 | $63.73 | $1,211 |
By year: 2022 $51K for 754 services; 2023 $32K for 577 services; 2024 $28K for 508 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ravi Pande prescribed most often to Medicare patients was Levetiracetam, with 459 prescriptions and refills. In total Ravi Pande wrote 3,418 Medicare prescriptions that cost $821K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 459 | 608 | 89 | $9,632 |
| Amitriptyline Hcl Generic | 273 | 325 | 58 | $1,855 |
| Primidone Generic | 239 | 320 | 43 | $3,348 |
| Gabapentin Generic | 207 | 238 | 37 | $2,999 |
| Donepezil Hcl Generic | 193 | 273 | 41 | $1,282 |
| Topiramate Generic | 165 | 229 | 35 | $1,508 |
| Phenytoin Sodium Extended Generic | 138 | 150 | 19 | $2,922 |
| Pregabalin Generic | 129 | 138 | 23 | $1,365 |
| Divalproex Sodium Er Divalproex Sodium | 127 | 191 | 31 | $2,863 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 113 | 127 | 15 | $1,387 |
| Duloxetine Hcl Generic | 76 | 121 | 17 | $1,068 |
| Divalproex Sodium Generic | 74 | 80 | 13 | $1,236 |
| Avonex Pen (4 Pack) Interferon Beta-1a | 65 | 65 | Under 11 | $530K |
| Ropinirole Hcl Generic | 62 | 70 | 11 | $895 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 57 | 84 | 14 | $1,061 |
Brand drugs: 144 claims; generic drugs: 3,241 claims; opioid claims: 73.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ravi Pande $127 ($127 in general payments such as food, travel and fees) from 5 companies. The largest payer was Amgen Inc. with $49.68.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.